Huri Özdoğan
Impact in
- Nephrology top 1%
- Gout, Hyperuricemia, Uric Acid
- Ophthalmology top 0.5%
- Ocular Diseases and Behçet’s Syndrome
- Retinal and Optic Conditions
Papers in
- Rheumatology 34
- Systemic Lupus Erythematosus Research 13
- Nephrology 14
- Gout, Hyperuricemia, Uric Acid 12
- Co-authors
- Serdal UğurluHasan YazıcıSeza ÖzenÖzgür KasapçopurEmire SeyahiAvi LivnehEldad Ben‐ChetritTilmann Kallinich
- Journals
- Annals of the Rheumatic Diseases (26 papers)Pediatric Rheumatology (12 papers)Lara D. Veeken (8 papers)The Journal of Pediatrics (2 papers)Clinical Rheumatology (2 papers)
- Partner nations
- TürkiyeUnited StatesItaly
In The Last Decade
Huri Özdoğan
102 papers receiving 3.1k citations
Peers
Comparison fields: 5 of 91
- Nephrology 584
- Ophthalmology 698
- Hematology 581
- Immunology 1.1k
- Rheumatology 658
Countries citing papers authored by Huri Özdoğan
This map shows the geographic impact of Huri Özdoğan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huri Özdoğan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huri Özdoğan more than expected).
Fields of papers citing papers by Huri Özdoğan
This network shows the impact of papers produced by Huri Özdoğan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huri Özdoğan. The network helps show where Huri Özdoğan may publish in the future.
Co-authors
The 25 scholars most cited alongside Huri Özdoğan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2022 | 6 | |
| 3 | 2021 | 1 | |
| 4 | 2020 | 50 | |
| 5 | 2020 | 12 | |
| 6 | 2019 | 111 | |
| 7 | Exacerbation of Behçet's syndrome and familial Mediterranean fever with menstruation. | 2018 | 11 |
| 8 | Improvement of Disease Activity in Patients with Colchicine-Resistant FMF, Hids/Mkd and TRAPS Assessed By Autoinflammatory Disease Activity Index (AIDAI): Results from a Randomized Phase III Trial | 2017 | 2 |
| 9 | 2017 | 88 | |
| 10 | 2017 | 36 | |
| 11 | 2017 | 19 | |
| 12 | 2017 | 10 | |
| 13 | 2015 | 3 | |
| 14 | 2011 | 6 | |
| 15 | 2010 | 1 | |
| 16 | Jüvenil İdyopatik Artrit Tedavisinde Anti-TNF Ajanlar | 2010 | 1 |
| 17 | 2008 | 5 | |
| 18 | 2004 | 17 | |
| 19 | The other physician behind the use of colchicine for the treatment of familial Mediterranean fever. | 2002 | 3 |
| 20 | 1994 | 7 |
About Huri Özdoğan
Huri Özdoğan is a scholar working on Rheumatology, Nephrology, Hematology, Immunology and Ophthalmology, having authored 108 papers that have together received 3.2k indexed citations. Recurring topics across this work include Inflammasome and immune disorders (59 papers), Autoimmune and Inflammatory Disorders Research (21 papers), Systemic Lupus Erythematosus Research (13 papers), Ocular Diseases and Behçet’s Syndrome (12 papers), Gout, Hyperuricemia, Uric Acid (12 papers), interferon and immune responses (11 papers), Kawasaki Disease and Coronary Complications (10 papers) and Vasculitis and related conditions (9 papers). The work is most often cited by research in Nephrology (584 citations), Ophthalmology (698 citations), Hematology (581 citations), Immunology (1.1k citations) and Rheumatology (658 citations). Huri Özdoğan has collaborated with scholars based in Türkiye, United States and Italy. Frequent co-authors include Serdal Uğurlu, Hasan Yazıcı, Seza Özen, Özgür Kasapçopur, Emire Seyahi, Avi Livneh, Eldad Ben‐Chetrit, Tilmann Kallinich, Nı̇l Arısoy and Sebahattin Yurdakul. Their work appears in journals such as Annals of the Rheumatic Diseases, Pediatric Rheumatology, Lara D. Veeken, The Journal of Pediatrics and Clinical Rheumatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.